Turner Overton, M.D., is Professor of Medicine at the University of Alabama School of Medicine and Medical Director of the University of Alabama 1917 HIV Clinic. Dr. Overton earned his medical degree at the University of Tennessee College of Medicine. He then completed his Internal Medicine Residency at University of Alabama Hospitals and his Infectious Diseases Fellowship at Barnes-Jewish Hospital and Washington University.
Dr. Overton’s area of research involves metabolic complications of HIV, including osteoporosis, diabetes, hyperlipidemia, and cardiovascular disease and he has numerous peer-reviewed publications in this area. He also serves as a member of the End Organ Disease/Inflammation Transformative Science Group for the AIDS Clinical Trials Group and has led multiple clinical trials.
Dr. Overton is Co-Chair of the REPRIEVE protocol and Chair of the Protocol Writing and Implementation Committee.